- Trials with a EudraCT protocol (5)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
5 result(s) found for: Phytomenadione.
Displaying page 1 of 1.
EudraCT Number: 2010-021264-14 | Sponsor Protocol Number: 10-003 | Start Date*: 2012-09-25 |
Sponsor Name:RWTH Aachen University represented by the rector, himself represented by the dean of the Medical Faculty | ||
Full Title: Vitamin K1 to slow vascular calcification in hemodialysis patients. Multicenter, multinational, randomized controlled clinical trial | ||
Medical condition: dialysis patients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-006238-87 | Sponsor Protocol Number: 4717 | Start Date*: 2010-01-22 |
Sponsor Name:Newcastle upon Tyne Hospitals NHS Foundation Trust | ||
Full Title: Improving the safety and efficacy of anticoagulation therapy for thromboembolic disease through vitamin K | ||
Medical condition: Patients will be recruited who are receiving long term warfarin therapy for the treatment or prevention of venous or arterial thrombosis or embolism | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2010-022826-34 | Sponsor Protocol Number: 08092010 | Start Date*: 2011-04-28 | ||||||||||||||||||||||||||
Sponsor Name: | ||||||||||||||||||||||||||||
Full Title: Randomised trial to investigate possible differences in biological availability and effectiveness between vitamin K solution in oil and vitamin K tablets. | ||||||||||||||||||||||||||||
Medical condition: Lowering anticoagulant effect of vitamin K antagonists in case of over-anticoagulation or pending diagnostic or therapeutic invase action. | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-015858-38 | Sponsor Protocol Number: ACENO-K-01-2009 | Start Date*: 2011-05-26 |
Sponsor Name:Dr. Antonio Javier Trujillo Santos | ||
Full Title: Comparación de la adición de bajas dosis de vitamina K al tratamiento con acenocumarol frente al tratamiento tradicional con acenocumarol sobre la estabilidad del efecto anticoagulante y sus compli... | ||
Medical condition: Pacientes que precisen de anticoagulación oral con cumarinas durante al menos 3 meses, fundamentalmente son pacientes con arritmias cardíacas (sobre todo fibrilación auricular) y enfermedad tromboe... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-004578-15 | Sponsor Protocol Number: 01082007 | Start Date*: 2008-03-03 | ||||||||||||||||||||||||||
Sponsor Name:Dutch Heart Foundation | ||||||||||||||||||||||||||||
Full Title: A randomised, double blind placebo controlled trial to (A) assess the optimal vitamin K dosage for supplementation, and (B) to access whether complications of anticoagulation treatment will diminis... | ||||||||||||||||||||||||||||
Medical condition: Anti-coagulationtreatment with vitamine K antagonists. | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
